Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WDFY3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NGLY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDIA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDGF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR89 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENDOD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDCD6IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPEPPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GABPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2V2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EDEM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on